Skip to main content
Fig. 4 | BMC Gastroenterology

Fig. 4

From: Antiviral therapy reduces rebleeding rate in patients with hepatitis B-related cirrhosis with acute variceal bleeding after endotherapy

Fig. 4

The cumulative rebleeding and survival rates at different time points by IPTW analysis (N = 1139; 216 in the non-antiviral group vs. 923 in the antiviral group). a, rebleeding rate at 1 year; b, rebleeding rate at 2 years; c, rebleeding rate at 3 years; d, rebleeding rate at 5 years; e, survival rate at 1 year; f, survival rate at 2 years; g, survival rate at 3 years; h, survival rate at 5 years

Back to article page